Abstract: Examples described herein relate to circuitry to provide telemetry data of first circuitry based on a power state of the first circuitry and provide telemetry data of second circuitry based on a power state of the second circuitry.

Abstract: Techniques for debugging a confidential virtual machine for a processor in production mode are described. In certain examples, a hardware processor core is to implement: a trust domain manager to manage one or more hardware isolated virtual machines as a respective trust domain with a region of memory protected by a respective encryption key, and a virtual machine monitor that is not allowed access to the protected region of memory of the one or more hardware isolated virtual machines; and a memory management circuit coupled between the hardware processor core and the memory, wherein, in response to a hardware isolated virtual machine generating a memory dump file, the trust domain manager is to encrypt the memory dump file with a debug key that is different from any of the respective encryption key to generate an encrypted memory dump file, and store the encrypted memory dump file in a portion of the memory that is accessible by the virtual machine monitor.

Abstract: Various examples of the present disclosure relate to an apparatus, device, method, and computer program for a network element, to a corresponding network element and to a system.

Abstract: Examples described herein relate to circuitry to provide telemetry data of first circuitry based on a power state of the first circuitry and provide telemetry data of second circuitry based on a power state of the second circuitry.

Abstract: An aspect of the present disclosure is directed to an oral liquid composition comprising valsartan with enhanced solubility and stability. Other aspects are directed to methods of using the oral liquid compositions for the treatment of hypertension, treatment of heart failure and reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction.

Abstract: The invention provides compositions that increase the mobilization, homing, expansion, and/or differentiation of stem cells and methods of using the same for the treatment of mammals.

Abstract: The invention provides compositions that increase the mobilization, homing, expansion, and/or differentiation of stem cells and methods of using the same for the treatment of mammals.

Abstract: An aspect of the present disclosure is directed to an oral liquid composition comprising valsartan with enhanced solubility and stability. Other aspects are directed to methods of using the oral liquid compositions for the treatment of hypertension, treatment of heart failure and reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction.

Abstract: An uninterruptible power supply adapted to be connected between an AC line and a load, comprising a battery system, an inverter, and a transformer, and a controller. The battery system stores battery power. The inverter is operatively connected to the battery system. The transformer is operatively connected to the AC line, the load, and an inverter winding operatively connected to the inverter. The controller controls the inverter to supply power to the primary winding using battery power stored in the battery system based on a cost value indicative of reduction of life of the battery system.

Abstract: An aspect of the present disclosure is directed to an oral liquid composition comprising valsartan with enhanced solubility and stability. Other aspects are directed to methods of using the oral liquid compositions for the treatment of hypertension, treatment of heart failure and reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction.

Abstract: The present disclosure provides an oral liquid composition comprising valsartan with enhanced solubility and stability. Also, provided herein are methods of using the oral liquid compositions for the treatment of hypertension, treatment of heart failure and reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction.

Abstract: An aspect of the present disclosure is directed to an oral liquid composition comprising valsartan with enhanced solubility and stability. Other aspects are directed to methods of using the oral liquid compositions for the treatment of hypertension, treatment of heart failure and reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction.

Abstract: An uninterruptible power supply adapted to be connected between an AC line and a load, comprising a battery system, an inverter, and a transformer, and a controller. The battery system stores battery power. The inverter is operatively connected to the battery system. The transformer is operatively connected to the AC line, the load, and an inverter winding operatively connected to the inverter. The controller controls the inverter to supply power to the primary winding using battery power stored in the battery system based on a cost value indicative of reduction of life of the battery system.

Abstract: An uninterruptible power supply adapted to be connected between an AC line and a load a battery system for storing battery power, an inverter, a transformer, and a controller. The inverter is operatively connected to the battery system. The transformer comprises a primary winding adapted to be operatively connected to the AC line, a load winding adapted to be operatively connected to the load, and an inverter winding operatively connected to the inverter. The controller controls the inverter to operate in a first mode in which the inverter supplies power to the battery system, a second mode in which the inverter supplies power to the load winding using battery power stored in the battery system, and, based on a cost value indicative of reduction of life of the battery system, a third mode in which the inverter supplies power to the primary winding using battery power stored in the battery system.

Abstract: A heating ventilation and cooling system includes an energy recovery ventilator (ERV). The ERV is configured to produce an inlet airstream and an exhaust airstream. An enthalpy wheel within the energy recovery ventilator is operable to transport heat between the inlet and exhaust airstreams. A pressure transducer is configured to determine a backpressure across the enthalpy wheel. A controller is configured to determine, in response to the backpressure, an operational characteristic of the enthalpy wheel.

Abstract: The invention provides a method of inhibiting the effects of platelet activating factor (PAF). For instance, a disease or condition mediated by PAF (particularly inflammation) can be treated or platelet aggregation can be inhibited. The invention also provides a method of inhibiting the production and/or release of interleukin 8 (IL-8) by cells. The effects of PAF and the production and/or release of IL-8 are inhibited according to the invention by a compound of the formula: wherein R1 and R2 are defined in the application, or a physiologically-acceptable salt thereof. The invention also provides pharmaceutical compositions comprising these compounds.

Abstract: The invention provides compositions that increase the mobilization, homing, expansion, and/or differentiation of stem cells and methods of using the same for the treatment of mammals.

Abstract: An uninterruptible power supply adapted to be connected between an AC line and a load a battery system for storing battery power, an inverter, a transformer, and a controller. The inverter is operatively connected to the battery system. The transformer comprises a primary winding adapted to be operatively connected to the AC line, a load winding adapted to be operatively connected to the load, and an inverter winding operatively connected to the inverter. The controller controls the inverter to operate in a first mode in which the inverter supplies power to the battery system, a second mode in which the inverter supplies power to the load winding using battery power stored in the battery system, and, based on a cost value indicative of reduction of life of the battery system, a third mode in which the inverter supplies power to the primary winding using battery power stored in the battery system.

Abstract: The invention provides compositions that increase the mobilization, homing, expansion, and/or differentiation of stem cells and methods of using the same for the treatment of mammals.